Cempra

Cempra

closed
Cempra develops innovative antibiotics to address critical unmet medical needs. Their two lead products, currently in clinical development, target drug-resistant bacterial infections in both hospital and community settings.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR20152016
R&D budget61.0m60.0m

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$22.0m

Series A
N/A

$10.0m

Series B
N/A

$46.0m

Series C
N/A

N/A

IPO
N/A

$25.1m

Post IPO Equity
Total Funding€70.9m

Recent News about Cempra

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Cempra

Edit
Melinta
ACQUISITION by Cempra Aug 2017